Plain-English translation of NCT06207851 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called Nexsphere-F, which uses a minimally invasive procedure to target and reduce pain in the elbow or wrist. The procedure works by using tiny beads to decrease blood flow to the abnormal blood vessels that are causing your pain. Researchers want to see if this treatment is safe and effective for people whose chronic pain hasn't gotten better with standard treatments like anti-inflammatory medications, physical therapy, or steroid injections.
Many people with chronic elbow or wrist pain don't get relief from standard treatments, and they need other options. This trial exists to see if this new minimally invasive procedure can help reduce pain and improve quality of life for patients who have already tried conventional approaches without success.
If you qualify, you will undergo an imaging test to identify the abnormal blood vessels causing your pain. If they are found, the doctor will perform the minimally invasive procedure using Nexsphere-F to reduce blood flow to those vessels. You will then be followed up at multiple visits over 6 months, with visits happening at 2–7 days after the procedure, at 1 month, at 3 months, and at 6 months. At each visit, your pain level and function will be measured, and the research team will monitor for any side effects or complications.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
South Korea
Sponsor
Next Biomedical Co., Ltd.
Enrollment target
~38 participants
Started
July 2023
Primary completion
July 2026
Age range
19 Years – 80 Years
Last updated on clinicaltrials.gov in March 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sang Woo Park
Konkuk Hospital